SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-022276
Filing Date
2023-06-15
Accepted
2023-06-15 16:56:14
Documents
14
Period of Report
2023-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K espr-20230615.htm   iXBRL 8-K 62335
2 EX-3.1 exhibit3162023.htm EX-3.1 6523
3 EX-10.1 exhibit10162023.htm EX-10.1 112974
  Complete submission text file 0001628280-23-022276.txt   354210

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20230615.xsd EX-101.SCH 1917
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20230615_lab.xml EX-101.LAB 25852
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20230615_pre.xml EX-101.PRE 13595
8 EXTRACTED XBRL INSTANCE DOCUMENT espr-20230615_htm.xml XML 11512
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 231018169
SIC: 2834 Pharmaceutical Preparations